2015
DOI: 10.1002/btpr.2185
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of naringenin andp-coumaric acid hydroxylation using the nativeE. colihydroxylase complex, HpaBC

Abstract: Flavonoids are a growing class of bioactive natural products with distinct and interesting bioactivity both in vitro and in vivo. The extraction of flavonoids from plant sources is limited by their low natural abundance and commonly results in a mixture of products that are difficult to separate. However, due to recent advances, the microbial production of plant natural products has developed as a promising alternative for flavonoid production. Through optimization of media, induction temperature, induction po… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
52
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 62 publications
(54 citation statements)
references
References 23 publications
1
52
1
Order By: Relevance
“…Recent efforts from two labs have, however, enabled the near-gram-scale de novo production of both p -coumaric and caffeic acids (18, 19). The development of the tyrosine-overproducing E. coli strain rpoA14(DE3) represents a major milestone for the de novo production of phenylpropanoic acids (20, 21), while the discovery and optimization of the natively silenced E. coli non-P450 hydroxylase HpaBC enabled, for the first time, efficient production of caffeic acid through the ortho-hydroxylation of p -coumaric acid (18, 2224). Building off of these efforts, we first set out to develop a phenylpropanoic acid production module that was compatible with our previously described “C5” and “p168” modules to enable the de novo production of flavan-3-ols in vivo (9).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Recent efforts from two labs have, however, enabled the near-gram-scale de novo production of both p -coumaric and caffeic acids (18, 19). The development of the tyrosine-overproducing E. coli strain rpoA14(DE3) represents a major milestone for the de novo production of phenylpropanoic acids (20, 21), while the discovery and optimization of the natively silenced E. coli non-P450 hydroxylase HpaBC enabled, for the first time, efficient production of caffeic acid through the ortho-hydroxylation of p -coumaric acid (18, 2224). Building off of these efforts, we first set out to develop a phenylpropanoic acid production module that was compatible with our previously described “C5” and “p168” modules to enable the de novo production of flavan-3-ols in vivo (9).…”
Section: Resultsmentioning
confidence: 99%
“…The corresponding plasmid was sequence verified (Genewiz, Inc.) and used together with pETM6-HpaBC (no. 12 in Table S1) (22) to create pETM6- Rg TAL syn -HpaB-HpaC through standard ePathBrick cloning protocols (37). …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…We tested the HpaBC gene, encoding 4-hydroxyphenylacetate 3-hydroxylase, from E. coli 25 and Sam5 from Saccharothrix espanaensis 26 in order to convert tyrosol into hydroxytyrosol. HpaBC and Sam5 were used to modify other phenolic compounds such as p -coumaric acid, tyrosine, and flavonoids 2729 . The HpaBC or Sam5 genes were coexpressed with PcAAS in E. coli , and each transformant was tested for the production of hydroxytyrosol.…”
Section: Resultsmentioning
confidence: 99%
“…Additional strategies and methods, described in the following sections, are being explored to enhance the expression level. After optimization for chromosomal integration of target genes or metabolic pathways, at least for some proteins, the capability of protein expression from chromosomal integration surpasses high copy plasmid‐based expression systems (Englaender et al, ; Jones, Collins, Vernacchio, Lachance, & Koffas, ; Wang et al, ).…”
Section: Introductionmentioning
confidence: 99%